share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Dmytruk Mark E.

Ginkgo Bioworks | 4:持股变动声明-高管 Dmytruk Mark E.

SEC announcement ·  03/08 17:01
Moomoo AI 已提取核心信息
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), has been involved in a transaction dated 03/07/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Dmytruk to the issuer is noted as 'See remarks,' suggesting further details might be available in the full report or additional documentation.
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), has been involved in a transaction dated 03/07/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Dmytruk to the issuer is noted as 'See remarks,' suggesting further details might be available in the full report or additional documentation.
与Ginkgo Bioworks Holdings, Inc.(交易代码DNA.US)相关的马克·德米特鲁克参与了2024年7月3日的一笔交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。Dmytruk与发行人的关系被称为 “见备注”,这表明更多细节可能会在报告全文或其他文件中找到。
与Ginkgo Bioworks Holdings, Inc.(交易代码DNA.US)相关的马克·德米特鲁克参与了2024年7月3日的一笔交易。公告中未披露该交易的具体细节,包括股票数量、股票性质、交易价格和股票总价值。Dmytruk与发行人的关系被称为 “见备注”,这表明更多细节可能会在报告全文或其他文件中找到。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息